Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
1.
Cell Rep Med ; 3(11): 100820, 2022 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-36384103

RESUMEN

Ideal therapies for regenerative medicine or healthy aging require healthy organ growth and rejuvenation, but no organ-level approach is currently available. Using Mycobacterium leprae (ML) with natural partial cellular reprogramming capacity and its animal host nine-banded armadillos, we present an evolutionarily refined model of adult liver growth and regeneration. In infected armadillos, ML reprogram the entire liver and significantly increase total liver/body weight ratio by increasing healthy liver lobules, including hepatocyte proliferation and proportionate expansion of vasculature, and biliary systems. ML-infected livers are microarchitecturally and functionally normal without damage, fibrosis, or tumorigenesis. Bacteria-induced reprogramming reactivates liver progenitor/developmental/fetal genes and upregulates growth-, metabolism-, and anti-aging-associated markers with minimal change in senescence and tumorigenic genes, suggesting bacterial hijacking of homeostatic, regeneration pathways to promote de novo organogenesis. This may facilitate the unraveling of endogenous pathways that effectively and safely re-engage liver organ growth, with broad therapeutic implications including organ regeneration and rejuvenation.


Asunto(s)
Armadillos , Reprogramación Celular , Animales , Hígado/metabolismo , Carcinogénesis/metabolismo , Fibrosis , Bacterias
2.
Int J Exp Pathol ; 103(6): 234-244, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36183172

RESUMEN

Fibrosis is a common pathophysiological response of many tissues and organs subjected to chronic injury. Despite the diverse aetiology of keloid, lacaziosis and localized scleroderma, the process of fibrosis is present in the pathogenesis of all of these three entities beyond other individual clinical and histological distinct characteristics. Fibrosis was studied in 20 samples each of these three chronic cutaneous inflammatory diseases. An immunohistochemical study was carried out to explore the presence of α-smooth muscle actin (α-SMA) and vimentin cytoskeleton antigens, CD31, CD34, Ki67, p16; CD105, CD163, CD206 and FOXP3 antigens; and the central fibrotic cytokine TGF-ß. Higher expression of vimentin in comparison to α-SMA in all three lesion types was found. CD31- and CD34-positive blood vessel endothelial cells were observed throughout the reticular dermis. Ki67 expression was low and almost absent in scleroderma. p16-positive levels were higher than ki67 and observed in reticular dermis of keloidal collagen in keloids, in collagen bundles in scleroderma and in the external layers of the granulomas in lacaziosis. The presence of α-actin positive cells and rarely CD34 positive cells, observed primarily in keloids, may be related to higher p16 antigen expression, a measure of cell senescence. Low FOXP3 expression was observed in all lesion types. CD105-positive cells were mainly found in perivascular tissue in close contact with the adventitia in keloids and scleroderma, while, in lacaziosis, these cells were chiefly observed in conjunction with collagen deposition in the external granuloma layer. We did not find high involvement of CD163 or CD206-positive cells in the fibrotic process. TGF-ß was notable only in keloid and lacaziosis lesions. In conclusion, we have suggested vimentin to be the main myofibroblast general marker of the fibrotic process in all three studied diseases, while endothelial-to-mesenchymal transition (EndoMT) and mesenchymal stem cells (MSCs) and M2 macrophages may not play an important role.


Asunto(s)
Queloide , Lobomicosis , Esclerodermia Localizada , Piel , Humanos , Células Endoteliales/metabolismo , Células Endoteliales/patología , Fibroblastos/metabolismo , Fibrosis , Factores de Transcripción Forkhead/metabolismo , Queloide/metabolismo , Queloide/patología , Antígeno Ki-67/metabolismo , Lobomicosis/patología , Esclerodermia Localizada/metabolismo , Esclerodermia Localizada/patología , Piel/metabolismo , Piel/patología , Factor de Crecimiento Transformador beta/metabolismo , Vimentina/metabolismo
6.
Mem Inst Oswaldo Cruz ; 114: e190056, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31389520

RESUMEN

BACKGROUND: Fibrosis in the peripheral nerve is the end stage of leprous neuropathy and the cause of the resulting permanent neural function impairments. Preventive measures to avoid this irreversible pathological state are a relief strategy for leprosy sufferers. OBJECTIVES: The present study describes the frequency of fibrosis along with its characterisation and pathogenic development. METHODS: Six-hundred-and-thirteen nerve samples were sorted from 278 neural leprosy (NL) and 335 non-leprosy neuropathy patients (ON). The total number of samples was histologically examined by routine staining methods (haematoxylin-eosin, Wade staining and Gomori's trichrome) and fibrosis was evaluated via semi-quantitative estimation. FINDINGS: Fibrosis was most frequent in the NL group (33% against 0.4% in ON) while fibrosis in association with endoneurial microfasciculation was found in 38 (41.3%) of the NL samples in the examination of semithin sections. Pericytic activation in the perivascular environment was confirmed to be the source of the fibroblasts and perineurial cells delimiting microfascicles. End-stage fibrosis in leprosy displays an arrangement of microfascicles devoid of neural components (i.e., Schwann cells and axons) lined by an intermediate phenotype of fibroblastic-perineurial cells filled with bundles of collagen fibres. MAIN CONCLUSIONS: The present study underscores that fibrosis is frequently the severe end stage of neural leprosy NL pathogeny after analysing the notably distinct development of fibrosis within the neural environment.


Asunto(s)
Fibrosis/patología , Lepra Tuberculoide/patología , Nervios Periféricos/patología , Biopsia , Humanos , Inmunohistoquímica , Enfermedades del Sistema Nervioso Periférico/patología , Células de Schwann/patología
9.
Mem. Inst. Oswaldo Cruz ; 114: e190056, 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1012667

RESUMEN

BACKGROUND Fibrosis in the peripheral nerve is the end stage of leprous neuropathy and the cause of the resulting permanent neural function impairments. Preventive measures to avoid this irreversible pathological state are a relief strategy for leprosy sufferers. OBJECTIVES The present study describes the frequency of fibrosis along with its characterisation and pathogenic development. METHODS Six-hundred-and-thirteen nerve samples were sorted from 278 neural leprosy (NL) and 335 non-leprosy neuropathy patients (ON). The total number of samples was histologically examined by routine staining methods (haematoxylin-eosin, Wade staining and Gomori's trichrome) and fibrosis was evaluated via semi-quantitative estimation. FINDINGS Fibrosis was most frequent in the NL group (33% against 0.4% in ON) while fibrosis in association with endoneurial microfasciculation was found in 38 (41.3%) of the NL samples in the examination of semithin sections. Pericytic activation in the perivascular environment was confirmed to be the source of the fibroblasts and perineurial cells delimiting microfascicles. End-stage fibrosis in leprosy displays an arrangement of microfascicles devoid of neural components (i.e., Schwann cells and axons) lined by an intermediate phenotype of fibroblastic-perineurial cells filled with bundles of collagen fibres. MAIN CONCLUSIONS The present study underscores that fibrosis is frequently the severe end stage of neural leprosy NL pathogeny after analysing the notably distinct development of fibrosis within the neural environment.


Asunto(s)
Humanos , Fibrosis/diagnóstico , Fibrosis/terapia , Lepra Tuberculoide/diagnóstico , Lepra Tuberculoide/prevención & control
10.
Clin Orthop Surg ; 7(4): 490-6, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26640633

RESUMEN

BACKGROUND: The purpose of this study was to report findings of exploratory arthroscopic assessment performed in conjunction with removal of internal fixation device placed in the initial surgery for rotational ankle fracture. METHODS: A total of 53 patients (33 male, 20 female) who underwent surgery for rotational ankle fracture between November 2002 and February 2008 were retrospectively reviewed. All patients gave consent to the exploratory arthroscopic surgery for the removal of internal fixation devices placed in the initial surgery. Lauge-Hansen classification system of ankle fractures was assessed for all patients. Intra-articular lesions (osteochondral lesion, loose body, and fibrosis) were evaluated via ankle arthroscopy. Comparative analysis was then performed between radiological classification of ankle fracture/patient's symptoms and arthroscopic findings. RESULTS: Lauge-Hansen classification system of ankle fractures included supination-external rotation type (n = 35), pronation-external rotation type (n = 9), and pronation-abduction type (n = 9). A total of 33 patients exhibited symptoms of pain or discomfort while walking whereas 20 exhibited no symptoms. Arthroscopic findings included abnormal findings around the syndesmosis area (n = 35), intra-articular fibrosis (n = 51), osteochondral lesions of the talus (n = 33), loose bodies (n = 6), synovitis (n = 13), and anterior bony impingement syndrome (n = 3). Intra-articular fibrosis was seen in 31 of symptomatic patients (93.9%). Pain or discomfort with activity caused by soft tissue impingement with meniscus-like intra-articular fibrosis were found in 19 patients. There was statistical significance (p = 0.02) between symptoms (pain and discomfort) and the findings of meniscus-like fibrosis compared to the group without any symptom. CONCLUSIONS: Arthroscopic examination combined with treatment of intra-articular fibrosis arising from ankle fracture surgery may help improve surgical outcomes.


Asunto(s)
Fracturas de Tobillo/patología , Fracturas de Tobillo/cirugía , Tobillo/patología , Tobillo/cirugía , Artroscopía/métodos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Tobillo/diagnóstico por imagen , Fracturas de Tobillo/diagnóstico por imagen , Artralgia , Femenino , Fibrosis , Humanos , Masculino , Persona de Mediana Edad , Radiografía , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
13.
J Neuropathol Exp Neurol ; 72(4): 351-66, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23481710

RESUMEN

Fibrosis is the main cause of irreversible nerve damage in leprosy. Phenotypic changes in Mycobacterium leprae (ML)-infected Schwann cells (SCs) have been suggested to mediate this process. We found that SC line cultures stimulated with ML upregulated transforming growth factor-ß1 (TGF-ß1), and that TGF-ß1 or ML induced increased numbers of α-smooth muscle actin (α-SMA)-positive cells with characteristic stress fibers. Mycobacterium leprae and TGF-ß1 also induced increased type I collagen and fibronectin mRNA and secretion and augmented mRNA levels of SOX9 and ZEB1, which are involved in the epithelial-mesenchymal transition. These effects could be inhibited by the TGF-ß1 type I receptor (ALK5) inhibitor, SB-431542. In nerve biopsies from leprosy-infected patients with varying grades of fibrosis (n = 11), type I and III collagen and fibronectin were found in the endoneurium and perineurium, α-SMA-positive cells filled the fibrotic perineurium but not the endoneurium, and CD34-positive fibroblasts predominated in the endoneurium. Results of transcriptional studies of 3 leprosy nerves and 5 controls were consistent with these data, but α-SMA and other mRNA levels were not different from those in the control samples. Our findings suggest that TGF-ß1 may orchestrate events, including reprogramming of the SC phenotype, leading to transdifferentiation, connective tissue cell expansion, and fibrogenesis in the evolution of leprosy nerve lesions during some evolutionary stages.


Asunto(s)
Lepra/patología , Mycobacterium leprae , Neuronas/patología , Factor de Crecimiento Transformador beta1/fisiología , Adulto , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Células Cultivadas , Femenino , Fibrosis , Humanos , Mediadores de Inflamación/metabolismo , Lepra/metabolismo , Masculino , Persona de Mediana Edad , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Células de Schwann/efectos de los fármacos , Células de Schwann/metabolismo , Células de Schwann/patología , Factor de Crecimiento Transformador beta1/toxicidad , Adulto Joven
15.
Rio de Janeiro; s.n; 2013. xi,77 p. ilus, graf.
Tesis en Portugués | LILACS | ID: lil-695548

RESUMEN

A fibrose é a principal causa de danos irreversíveis ao nervo periférico de pacientes com hanseníase. Células de Schwann (CS) infectadas com Mycobacterium leprae (ML) sofrem mudanças fenotípicas e podem ter características fibrogênicas. Considerando que o ML aumenta a expressão e a produção de TGF-Beta1 em culturas de CS, o efeito do TGF-Beta1 também foi investigado na transdiferenciação miofibroblástica da CS humana da linhagem ST88-14. CS da linhagem estimuladas com TGF-Beta1 ou ML tiveram um aumento de células positivas para α-actina de músculo liso (αSMA), apresentando fibras de estresse características. Os níveis aumentados de SOX9 e ZEB1, conhecidos por estarem envolvidos no processo de transição epitélio-mesenquimal, foram confirmados através de análise do RNAm, além da deposição de colágeno do tipo I e fibronectina. Os nervos de pacientes com hanseníase foram utilizados para identificar os fenótipos de células fibrogênicas, presentes nos nervos com diferentes graus de fibrose. Primeiro, foi observada a expressão de colágeno dos tipos I e III, e de fibronectina no endoneuro e no perineuro de todos os fragmentos de nervos utilizados. Células positivas para αSMA foram detectadas no perineuro fibrosado, enquanto nenhuma célula αSMA+pode ser detectada no endoneuro, no qual foi identificado o predomínio de fibroblastos endoneurais CD34+. A análise transcripcional dos nervos de pacientes com hanseníase confirmaram nossos dados anteriores, mas não houve diferença na expressão de RNAm de αSMA quando comparado com as amostras controles. Todos os resultados sugerem que o TGF-Beta orquestra uma infinidade de eventos na evolução fibrogênica das lesões de nervos de pacientes com hanseníase e poderia mediar a transdiferenciação miofibroblástica da CS em alguns estágios evolutivos da doença.


Asunto(s)
Enfermedades Endémicas , Fibrosis , Lepra , Mycobacterium leprae , Factor de Crecimiento Transformador beta1
16.
Biomedica ; 32(1): 13-22, 2012.
Artículo en Español | MEDLINE | ID: mdl-23235783

RESUMEN

INTRODUCTION: Damage of testicles is frequent in lepromatous leprosy and worsened by the presence of erythema nodosum leprosum. Objective. A patient is presented who developed lepromatous leprosy and erythema nodosum leprosum with major testicular compromise. MATERIAL AND METHODS: The 28-year-old male patient had lepromatous leprosy since age 22. During a polychemotherapy treatment for the lepromatous leprosy, he presented chronic erythema nodosum leprosum that affected both testicles; he did not respond to the conventional treatment. A left orchidectomy was performed to treat the persistent pain. RESULTS: The extracted testis evidenced the following: tubular atrophy, extensive fibrosis, cumulus of foamy macrophages without rods, focal Leydig cell hyperplasia, linfocitary and granulomatous arteritis and endarteritis of small and medium size vessels. These changes were also observed in the epididymis. Two years after the polychemoterapy and the orchidectomy, the patient exhibited azoospermy, normal total testosterone, slightly diminished free testosterone and elevated levels of luteinizing hormone and follicle-stimulating hormone. No loss of libido or sexual activity was reported. General concepts of erythema nodosum leprosum were reviewed, as well as the pathologic changes produced by leprosy in the testis. CONCLUSION: Lepromatous leprosy may lead to hypogonadism. This condition is recommended for inclusion in leprosy diagnostic programs in order to detect and treat the consequences of the possible hypogonadism.


Asunto(s)
Eritema Nudoso/etiología , Hipogonadismo/etiología , Lepra Lepromatosa/complicaciones , Enfermedades Testiculares/etiología , Adulto , Atrofia , Azoospermia/etiología , Clofazimina/uso terapéutico , Dapsona/uso terapéutico , Epidídimo/patología , Eritema Nudoso/patología , Eritema Nudoso/cirugía , Fibrosis , Células Espumosas/patología , Hormona Folículo Estimulante/sangre , Humanos , Hiperplasia , Hipogonadismo/sangre , Leprostáticos/uso terapéutico , Lepra Lepromatosa/clasificación , Lepra Lepromatosa/tratamiento farmacológico , Lepra Lepromatosa/inmunología , Lepra Lepromatosa/patología , Células Intersticiales del Testículo/patología , Hormona Luteinizante/sangre , Masculino , Orquiectomía , Rifampin/uso terapéutico , Enfermedades Testiculares/patología , Enfermedades Testiculares/cirugía , Testosterona/sangre , Talidomida/uso terapéutico
17.
Biomédica (Bogotá) ; 32(1): 13-22, ene.-mar. 2012. ilus, tab
Artículo en Español | LILACS | ID: lil-639807

RESUMEN

Introducción. La afección testicular es frecuente en la lepra lepromatosa, daño que se incrementa cuando cursa con eritema nudoso leproso. Objetivo. Presentar un paciente con lepra lepromatosa y eritema nudoso leproso con grave compromiso testicular. Materiales y métodos. Se estudió un hombre de 28 años con lepra lepromatosa desde los 22, que durante la poliquimioterapia para la lepra presentó eritema nudoso leproso crónico que afectó ambos testículos y no respondió al manejo convencional. El dolor persistente obligó a practicar orquidectomía izquierda. Resultados. Este testículo presentaba atrofia tubular y fibrosis notorias, conglomerados de macrófagos espumosos, sin bacilos, hiperplasia focal de células de Leydig, endarteritis y arteritis linfocitaria y granulomatosa de vasos pequeños y medianos; estos cambios también estaban presentes en el epidídimo. Un estudio llevado a cabo dos años después de terminar su tratamiento y de la orquidectomía izquierda, demostró azoospermia, testosterona total normal, testosterona libre discretamente disminuida y hormonas lutropina (luteinizante) y folitropina (estimulante del folículo) elevadas. No había disminución de la libido ni de su actividad sexual. Se revisaron los conceptos generales sobre el eritema nudoso leproso y las alteraciones que la lepra produce en el testículo. Conclusión. La lepra lepromatosa puede conducir a hipogonadismo. Los programas de lepra deben contemplar esta complicación para corregir y evitar sus secuelas.


Introduction. Damage of testicles is frequent in lepromatous leprosy and worsened by the presence of erythema nodosum leprosum. Objective. A patient is presented who developed lepromatous leprosy and erythema nodosum leprosum with major testicular compromise. Material and methods. The 28-year-old male patient had lepromatous leprosy since age 22. During a polychemotherapy treatment for the lepromatous leprosy, he presented chronic erythema nodosum leprosum that affected both testicles; he did not respond to the conventional treatment. A left orchidectomy was performed to treat the persistent pain. Results. The extracted testis evidenced the following: tubular atrophy, extensive fibrosis, cumulus of foamy macrophages without rods, focal Leydig cell hyperplasia, linfocitary and granulomatous arteritis and endarteritis of small and medium size vessels. These changes were also observed in the epididymis. Two years after the polychemoterapy and the orchidectomy, the patient exhibited azoospermy, normal total testosterone, slightly diminished free testosterone and elevated levels of luteinizing hormone and follicle-stimulating hormone. No loss of libido or sexual activity was reported. General concepts of erythema nodosum leprosum were reviewed, as well as the pathologic changes produced by leprosy in the testis. Conclusion. Lepromatous leprosy may lead to hypogonadism. This condition is recommended for inclusion in leprosy diagnostic programs in order to detect and treat the consequences of the possible hypogonadism.


Asunto(s)
Adulto , Humanos , Masculino , Eritema Nudoso/etiología , Hipogonadismo/etiología , Lepra Lepromatosa/complicaciones , Enfermedades Testiculares/etiología , Atrofia , Azoospermia/etiología , Clofazimina/uso terapéutico , Dapsona/uso terapéutico , Epidídimo/patología , Eritema Nudoso/patología , Eritema Nudoso/cirugía , Fibrosis , Células Espumosas/patología , Hormona Folículo Estimulante/sangre , Hiperplasia , Hipogonadismo/sangre , Leprostáticos/uso terapéutico , Lepra Lepromatosa/clasificación , Lepra Lepromatosa/tratamiento farmacológico , Lepra Lepromatosa/inmunología , Lepra Lepromatosa/patología , Células Intersticiales del Testículo/patología , Hormona Luteinizante/sangre , Orquiectomía , Rifampin/uso terapéutico , Enfermedades Testiculares/patología , Enfermedades Testiculares/cirugía , Testosterona/sangre , Talidomida/uso terapéutico
18.
Rev Invest Clin ; 61(3): 212-20, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19736810

RESUMEN

INTRODUCTION: Rheumatoid arthritis is an autoimmune inflammatory disease of unknown etiology, free radicals have been implicated in the genesis and perpetuation of damage in this pathology. OBJECTIVE: To evaluate the anti-inflammatory effect of Cu,Zn-superoxide dismutase (SOD) obtained from two different sources (bovine erythrocytes, Be-SOD, and Debaryomyces hansenii, Dh-SOD) with Type II Collagen-induced Arthritis model in rats. MATERIAL AND METHODS: Arthritis was induced by repeated injection of a porcine type II collagen-incomplete Freund adjuvant suspension on the back of Dark Augui (DA) rats. Arthritis was clinically evaluated throughout the study. Body weight was determined at three different times. Two different doses for each treatment (Be-SOD, Dh-SOD) were tested: 100 and 1,000 U/kg. At the end of the trial (day 28), histological analyses of the most inflamed ankle joint, as well as serum anti-collagen antibodies, were determined. RESULTS: Both sources of SOD decreased, although to a different extent, the incidence and severity of the disease. Arthritis score was lower in all treatments, except for the low dose of Be-SOD. Groups receiving either source of SOD showed a significant weight increase compared to the placebo group. Histological damage was similar in all groups. Only the group that received the highest dose of Dh-SOD showed a significant lower antibody titer; nevertheless, no correlation appears to derive from arthritis score and antibody titer. CONCLUSION: Our findings suggest that, although unable to counteract the arthritis syndrome, SOD may still be beneficial due to its anti-inflammatory activity. In the case of Dh-SOD, the best effect was observed at the highest dose tested.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Antirreumáticos/uso terapéutico , Artritis Experimental/tratamiento farmacológico , Debaryomyces/enzimología , Proteínas Fúngicas/uso terapéutico , Superóxido Dismutasa/uso terapéutico , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/aislamiento & purificación , Antirreumáticos/administración & dosificación , Antirreumáticos/aislamiento & purificación , Artritis Experimental/sangre , Artritis Experimental/patología , Artritis Experimental/prevención & control , Artritis Reumatoide , Autoanticuerpos/sangre , Bovinos , Colágeno Tipo II/toxicidad , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Eritrocitos/enzimología , Femenino , Fibrosis , Proteínas Fúngicas/administración & dosificación , Proteínas Fúngicas/aislamiento & purificación , Hiperplasia , Inyecciones Intraperitoneales , Ratas , Especificidad de la Especie , Superóxido Dismutasa/administración & dosificación , Superóxido Dismutasa/aislamiento & purificación
19.
Artículo en Inglés | MEDLINE | ID: mdl-18187819

RESUMEN

BACKGROUND: Tuberous sclerosis complex (TSC) is a neurocutaneous genodermatosis characterized by hamartoma formation in multiple organs. There are no definite cutaneous markers suggestive of central nervous system (CNS) involvement in TSC. AIMS: To study association of forehead plaque seen in tuberous sclerosis patients and CNS involvement in TSC. METHODS: This is a retrospective study of 15 cases of tuberous sclerosis in varying age groups - from 1.5 to 50 years. All the cases were thoroughly evaluated with detailed history; clinical examination; and relevant investigations like X-rays of chest, skull, hands and feet; ultrasound abdomen and computed tomography of brain. RESULTS: Out of the 15 cases, CNS involvement was seen in 8 cases. Seizures were present in 8 cases (53.33%) and mental retardation was seen in 6 cases (40%). Computerized tomography of brain revealed subependymal nodules (SENs) in eight cases (53.33%). In addition to SENs, subependymal giant cell astrocytomas and cortical tubers were seen in 2 cases each. Out of these 8 cases having CNS involvement, in 7 cases forehead plaque was observed. In 1 case, no forehead plaque was observed (X 2 = 1.07, P < 0.05). CONCLUSION: This study shows that there is a statistically significant relationship between the presence of a forehead plaque and CNS involvement in TSC. Therefore, forehead plaque may be considered as a novel cutaneous marker to know the CNS involvement in TSC at an early stage.


Asunto(s)
Encefalopatías/patología , Frente/patología , Piel/patología , Esclerosis Tuberosa/patología , Adolescente , Adulto , Niño , Preescolar , Femenino , Fibrosis , Humanos , Lactante , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
20.
J AAPOS ; 11(6): 626-7, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17720574

RESUMEN

Fibrosis of the extraocular muscles can be congenital or acquired. Acquired causes include trauma, myositis, thyroid eye disease, infection, and metastases. Congenital fibrosis of the extraocular muscles (CFEOM) runs in families and is known to have a genetic basis. It has been classified by Brown, Hansen, and Harley et al into the five following types: general fibrosis syndrome; fibrosis of the inferior rectus (IR) with blepharoptosis; strabismus fixus; vertical retraction syndrome; and unilateral fibrosis, blepharoptosis, and enophthalmos syndrome. In this report, a case of unilateral fibrosis with enophthalmos and blepharoptosis due to a fibrous band is described.


Asunto(s)
Enoftalmia/etiología , Músculos Oculomotores/patología , Oftalmoplejía/etiología , Enfermedades Orbitales/complicaciones , Adulto , Blefaroptosis/etiología , Femenino , Fibrosis/congénito , Fibrosis/diagnóstico por imagen , Humanos , Músculos Oculomotores/diagnóstico por imagen , Enfermedades Orbitales/diagnóstico por imagen , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA